Arjun V Balar

Dr. Arjun V Balar, MD, is an Associate Professor of Medicine at the NYU Grossman School of Medicine in New York, New York. He is the Director of the Genitourinary Medical Oncology Program and the Medical Director for the Clinical Trials Office at the NYU Langone Perlmutter Cancer Center. He primarily focuses on treating and managing genitourinary cancers, such as prostate cancer, bladder cancer, kidney cancer, and testicular cancer. He has pioneered the development of immunotherapies for bladder cancer and metastatic urothelial carcinoma and is an internationally recognized leader in bladder cancer clinical trials. His research concentration includes molecularly targeted therapy as well as immunotherapy. Dr. Balar leads the NYU genitourinary tumor registry which is a multidisciplinary effort involving clinical, basic science, and translational researchers to characterize the genomic and molecular makeup of genitourinary tumors and to better understand its impact on patient outcomes. He is the editor of the periodical Targeted Therapeutics in Oncology. Dr. Balar completed a residency at New York-Presbyterian Weill Cornell Medical Center and is fellowship-trained in oncology from Memorial Sloan Kettering Cancer Center.